Bridging the gap between theory and real-world deployment, this essential guide reveals how cognitive IoT is moving healthcare past passive data tracking to usher in a new era of autonomous, real-time, and life-saving patient care.
Table of ContentsPreface
Part 1: Foundations of AI in Medical Imaging and Healthcare Systems
1. Deep Learning for Medical Imaging Analysis: Techniques, Challenges, and ApplicationsAmrita, Khalil Haruna Aminu, Mustapha Mukhtar Muhammad and Ibrahim Nayaya Isah
1.1 Introduction
1.2 Literature Review
1.3 Deep Learning
Feedforward Neural Network
Convolutional Neural Network
Recurrent Neural Network
Autoencoder
Generative Adversarial Network
Transformer
Graph Neural Network
Self-Organizing Map
Capsule Network
Deep Reinforcement Learning
1.4 Medical Imaging
Medical Imaging Techniques
1.5 Role of Deep Learning in Medical Imaging
1.6 Key Contributions of DL in Medical Imaging
1.7 Conclusion
References
2. Secure and Intelligent Healthcare: Integrating Blockchain, Federated Learning, and Cognitive IoTAdarsh Tiwari, Renu Mishra, Sneha Sinha, Mamta Narwaria and Anmol Kr. Sah
2.1 Introduction
2.2 Cognitive IoT in Healthcare: Foundation and Relevance
2.3 Blockchain for Secure Health Data Exchange
2.4 Proposed Framework for Blockchain-Enabled CIoT Healthcare
2.5 Security, Privacy, and Compliance Considerations
2.6 Challenges and Future Directions
2.7 Some Proposed Framework and Its Validation
2.8 Conclusion
References
3. Artificial Intelligence in Nonalcoholic Fatty Liver Disease: Enhancing Prediction, Diagnosis, and Treatment OutcomesTanisha Salhotra, Amit Kumar Singh, Vivek Kumar Garg and Aditya Kamboj
3.1 Introduction
3.2 Identifying the Patients at Risk of NAFLD
3.3 Diagnosis of NAFLD Severity
3.4 Utilizing AI for Early Identification and Risk Categorization
3.5 Digital Pathology: AI-Powered Analysis of Biopsy Samples
3.6 Predicting Disease Progression
3.7 AI-Driven Imaging Techniques for Diagnosing NAFLD
3.8 Using AI to Advance NAFLD Drug Discovery and Clinical Trials NAFLD
3.9 Conclusion
List of Abbreviations
References
4. AI-Driven Early Disease DetectionK. Deepa, N. Sharmila Banu and G. Dhanraj
4.1 Introduction
4.2 Cognitive Impairment: Definitions, Prevalence, and Clinical Impact
4.3 Concept of Cognitive IoT
4.3.1 Core Features
4.3.2 IoT Devices in Cognitive Healthcare
4.3.3 Transformative Shift
4.4 Data Flow in Cognitive IoT Systems for Cognitive Health
Monitoring
4.4.1 Architecture of Cognitive IoT Systems
4.4.2 Data Gathering
4.4.3 Edge Computing
4.4.4 Cloud Analytics
4.4.5 Integration
4.5 AI Techniques in Cognitive IoT
4.5.1 Supervised Learning
4.5.2 Deep Learning
4.5.3 Natural Language Processing (NLP)
4.5.4 Reinforcement Learning (RL)
4.6 Enabling Technologies (Compressed)
4.6.1 Internet of Medical Things (IoMT)
4.6.2 Edge Computing
4.6.3 Cloud Computing
4.6.4 Big Data Analytics
4.6.5 Communication Protocols
4.7 Digital Biomarkers and Data Analytics
4.7.1 Key Digital Biomarkers
4.8 Wearable Devices in Clinical Trials
4.8.1 Patient Engagement
4.8.2 Speech Analytics
4.9 Challenges and Limitations
4.10 Future Directions
4.11 Conclusion
References
Part 2: Advanced Predictive Modeling and Diagnostic Applications
5. Modeling of Smart Health Systems with Delay Differential
Equations for Predictive AnalyticsPankaj Kumar, Pankaj Rai and Bimal Kumar Mishra
5.1 Introduction
5.2 Literature Review
5.3 Mathematical Model
5.3.1 Basic TDDE Formulation
5.3.2 Existence of the Solution for the Proposed DDE Model
5.3.3 Equilibrium and Linear Stability Analysis
5.3.4 Lyapunov-Based Global Stability
5.3.5 Sensitivity Analysis
5.3.6 AI-Augmented Delay Estimation
5.3.7 Application to ICU Patient Flow
5.4 Numerical Simulation and Validation
5.4.1 Simulation Methodology
5.4.2 Computational Implementation
5.4.3 Results
5.4.3.1 Impact of Delay (τ)
5.4.3.2 Effect of Treatment Efficacy (α)
5.4.3.3 Effect of Health Degradation Rate (β) on Health Dynamics
5.4.3.4 Comparison with ODE Model (No Delay)
5.4.4 Interpretation and Validation
5.5 Discussion
5.6 Conclusion
References
6. Neurodegenerative Disorders: An Overview of Parkinson
Disease, Alzheimer’s Disease, Dementia and Other ConditionsShreeya Arora, Namrata Dash and Kalpana Katiyar
6.1 Introduction
6.1.1 Socioeconomic Effects and Impact on Healthcare
6.2 Pathobiology of Neurodegeneration
6.2.1 Protein Misfolding, Aggregation, and Toxic Conformations
6.2.2 Dysfunction of Mitochondria and Failure of Energy Metabolism
6.2.3 Imbalance of Oxidative Stress and Redox Status
6.2.4 Excitotoxic Effects and Dysregulation of Calcium
6.2.5 Neuroinflammatory Responses: Actions of Microglia and Astrocytes
6.2.6 Disrupted Proteostasis and Impaired Autophagy-Lysosomal Pathways
6.3 Parkinson’s Disease (PD)
6.3.1 Genetic Components (SNCA, LRRK2, PARK2, PINK1, and DJ-1)
6.3.2 Key Pathological Features: Lewy Bodies and Dopaminergic Neuron Loss
6.3.3 Molecular Mechanisms: α-Synuclein Aggregation and Mitochondrial Stress
6.3.4 Clinical Manifestations: Motor and Non-Motor Symptoms
6.3.5 Diagnostic Indicators and Neuroimaging Techniques
6.3.6 Treatment Methods: Dopamine Replacement, Neurostimulation, and Emerging Neuroprotective Strategies
6.3.7 Case Study: Clinical and Molecular Differences in Early-Onset vs. Late-Onset Parkinson’s
6.4 Alzheimer’s Disease (AD)
6.4.1 Genetic and Epigenetic Risk Factors: APOE ε4, PSEN1/2, APP
6.4.2 The Amyloid Cascade Hypothesis and Tau Hyperphosphorylation
6.4.3 Synaptic Dysfunction and Network Connectivity Failure
6.4.4 Clinical Symptoms and Progression of Disease (MCI to Advanced AD)
6.4.5 Biomarkers in Fluids and Imaging (CSF Aβ42, Tau, PET Tracers)
6.4.6 Existing Pharmacological Treatments and New Anti-Amyloid/Tau Approaches
6.4.7 Case Study: Diagnostic Challenges between Familial and Sporadic Alzheimer’s
6.5 Dementia and Related Conditions
6.5.1 Classification and Neuropathological Features (Vascular Dementia, DLB, FTD, Mixed)
6.5.1.1 Dementia with Lewy Bodies (DLB) and Lewy Body (LB) Diseases (Including Parkinson’s Disease Dementia, PDD)
6.5.1.2 Frontotemporal Dementia (FTD)
6.5.1.3 Mixed Dementia
6.5.2 Molecular Mechanisms That Differentiate Dementia Subtypes
6.5.2.1 Vascular Mechanisms and Neuroinflammation
6.5.2.2 Genetics and Risk Factors
6.5.3 Clinical Progression and Differentiation in Diagnosis
6.5.3.1 Some of the Clinical Progressions are Mentioned Below
6.5.3.2 Diagnostic Challenges and Tools
6.5.4 Overlapping Conditions and Comorbidities with PD and AD
6.5.4.1 Clinical and Mechanistic Overlaps
6.5.4.2 Implications for Management and Prognosis
6.5.5 Case Study: Distinguishing Lewy Body Dementia from Dementia Associated with Parkinson’s
6.5.5.1 Case Study
6.5.5.2 Diagnostic Reasoning
6.6 Other Neurodegenerative Disorders
6.6.1 Huntington’s Disease: Expansion of Polyglutamine and Degeneration of Striatum
6.6.2 Amyotrophic Lateral Sclerosis (ALS)
6.6.3 Prion Disorders: Misfolded PrP and Mechanisms of Infectious Proteins
6.6.4 Rare Neurodegenerative Syndromes with Notable Emerging Research
6.6.5 Case Study: Huntington’s Disease—Clinical Application of Genetic Counseling
6.7 Diagnostics and Biomarker Development
6.7.1 Neuroimaging Techniques (MRI, PET, fMRI, and DTI)
6.7.2 Biomarker Panels in Cerebrospinal Fluid and Blood
6.7.3 Profiling Genomic, Transcriptomic, and Proteomic Data
6.7.4 Digital Biomarkers and Diagnostic Assistance through Artificial Intelligence
6.7.5 Case Study: Early Diagnosis Using Biomarkers in Alzheimer’s and Parkinson’s
6.8 Therapeutics and Translational Advances
6.8.1 Differentiating between Disease-Modifying Therapies and Symptomatic Treatment
6.8.2 Small-Molecule Inhibitors and Immunotherapy Options (Monoclonal Antibodies, Vaccines)
6.8.3 Cell Replacement Strategies: Neurons and Glia Derived from iPSCs
6.8.4 Approaches to Gene Therapy (AAV, CRISPR-Based)
6.8.5 Neuroprotective Agents and Modulators of Metabolism
6.8.6 Non-Pharmacological Strategies: Cognitive Rehabilitation and Lifestyle Changes
6.8.6.1 Cognitive Rehabilitation
6.8.7 Case Study: Patient Outcomes and Limitations in Deep Brain Stimulation for Parkinson’s
6.9 Future Directions in Neurodegenerative Research
6.9.1 Approaches to Precision and Personalized Medicine
6.9.2 Integration of Multiomics Data and Systems Biology Approaches
6.9.3 Predictive Modeling and Utilization of Digital Twins in Neurodegenerative Disease Progression
6.9.4 Challenges in Ethics, Regulation, and Clinical Trials
6.9.5 Case Study: Integration of Clinical Data Across AD, PD, and ALS for Personalized Medicine
6.10 Conclusion
6.10.1 A Unified Perspective on Common and Distinct Mechanisms
6.10.2 Clinical and Research Gaps
6.10.3 Pathways Forward for Advancing Translational Neuroscience
Bibliography
7. Deep Learning-Based Diagnostic System for Histopathological Detection of Uterine Cancer SubtypesSubbulakshmi T. and Atharva Bandekar
7.1 Introduction
Diagnostic Challenges in Endometrial Pathology
Background and Clinical Motivation
7.2 AI Advances in Histopathology: State of the Art and Gaps
7.2.1 Deep Learning for Tissue Classification
7.2.2 Digital Pathology and Telemedicine
7.2.3 Privacy and Federated Learning
7.2.4 Interpretability and Grad-CAM
7.2.5 Digital Twin and Clinical Decision Support
7.3 Proposed AI Pathology Pipeline Building Method
7.3.1 Preprocessing and Augmentation
7.3.2 Model Architecture
7.3.3 Federated Learning Setup
7.3.4 Explainability and Digital Twin Integration
7.3.5 Real-World Case Studies
7.4 Discussion: Implications and Future Directions
7.4.1 Limitations
7.4.2 Conclusion and Future Directions Real-World Impact
7.4.3 Future Research
Bibliography
8. AI-Powered Smart Prosthetics and Neural InterfacesJanu Chandak and Pery Patel
8.1 Introduction
8.1.1 AI Evolution in Prosthetics
8.1.2 Neural Interface Technologies Overview
8.2 Hardware Components
8.2.1 Electrode Technology
8.2.2 Wireless Data Transmission
8.3 AI Algorithms for Neural Decoding
8.3.1 Deep Learning for Movement Prediction
8.3.2 Real-Time Adaptability
8.4 Sensory Restoration Via Haptic Feedback
8.4.1 Texture and Pressure Simulation
8.4.2 Closed‐Loop Control
8.5 Ethical and Privacy Considerations
8.6 Applications in Rehabilitation and Performance
8.7 Challenges and Future Directions
References
Part 3: Intelligent Systems and Human-Machine Integration
9. Neural and Muscular Feedback-Driven Adaptive ProstheticsJanu Chandak and Pery Patel
9.1 Introduction
9.1.1 Evolution of Prosthetics from Mechanical to Neuro-Integrated Systems
9.1.2 Role of Cloud of Things (CloT) in Adaptive Healthcare
9.2 Physiological Signal Acquisition
9.2.1 Neural Signal Mapping (EEG, Invasive BCI)
9.2.2 Muscular Signal Acquisition (sEMG, IMU Sensors)
9.3 Signal Processing and AI Integration
9.3.1 Preprocessing Neural/Muscular Data
9.3.2 Machine Learning for Movement Prediction
9.4 Actuator and Feedback Systems
9.4.1 Motor Control Algorithms
9.4.2 Sensory Feedback Mechanisms
9.5 Case Studies
9.5.1 Lower Limb Gait Adaptation
9.5.2 Upper Limb Dexterity Restoration
9.6 Challenges and Limitations
9.7 Future Prospects in Adaptive Prosthetics
Bibliography
10. Decoding Brain Signals Using a Hybrid LSTM-CNN Deep Learning ModelSankalp Chakre, Sarvesh Chaudhari, Nirdosh Chavhan, Adwait Gondhalekar and Riddhi Mirajkar
10.1 Introduction
10.2 Literature Survey
10.3 Proposed Methodology
10.3.1 Data Acquisition
10.3.2 Data Preprocessing
10.3.2.1 Band-Pass Filtering
10.3.2.2 Channel Normalization
10.3.2.3 Artifact Removal
10.3.2.4 Segmentization into Fixed-Length Windows
10.3.2.5 Label Encoding and Annotation Mapping
10.3.3 Feature Extraction Using CNN
10.3.3.1 1D Convolution Layers for Spatial Feature Extraction
10.3.3.2 Batch Normalization and Dropout
10.3.3.3 Max-Pooling for Dimensionality Reduction
10.3.4 Temporal Feature Learning Using BiLSTM
10.3.4.1 Why Use BiLSTM for EEG Data?
10.3.4.2 BiLSTM Architecture for EEG Signals
10.3.4.3 Dropout for Overfitting Prevention
10.3.5 Classification Layer
10.3.5.1 Fully Connected Dense Layer
10.3.5.2 Softmax Activation Function for Multiclass Classification
10.3.5.3 Loss Function: Cross-Entropy Loss
10.3.5.4 Optimizer: Adam (Adaptive Moment Estimation)
10.3.6 Model Training and Evaluation
10.4 Result
10.4.1 LSTM Model
10.4.2 CNN Model
10.4.3 Performance of the Hybrid CNN-LSTM Model
10.4.4 Comparative Analysis of EEG Classification Models
10.4.5 Hybrid CNN-LSTM Model
10.5 Conclusion
10.6 Future Scope
References
11. Multimodal GNN-Based Recommendation System for Children’s Movies with Genre-Aware Evaluation and VisualizationLucky Harichandan and Satyabrata Lenka
11.1 Introduction
11.2 Related Work
11.3 Dataset and Preprocessing
11.3.1 Genre Cleaning and Encoding
11.3.2 Model Architecture
11.3.3 Mathematical Formulation
11.3.4 Embedding Layer
11.3.5 Graph Convolution Layer
11.3.6 Rating Prediction
11.3.7 Loss Function
11.4 Results and Discussion
11.5 Conclusion
References
12. Market Adoption Strategies for Cognitive IoT in Smart
HealthcareShrutika Mishra and Priyanshu Mishra
12.1 Introduction
12.2 Literature Review
12.3 Research Methodology
12.4 Limitations
12.5 Future Research Directions
References
Part 4: Data-Driven Healthcare Management and Cross-Domain Applications
13. Data-Driven Decision-Making in Healthcare Management Using Cognitive IoT: A Business and Management PerspectivePriyanshu Mishra and Shrutika Mishra
13.1 Introduction
13.2 Literature Review
13.3 Research Methodology
13.4 Future Directions
13.5 Conclusion
References
14. Predictive Analytics in HealthcareAmrita, Kabiru Uba Kiru and Saeed Aliyu Usman
14.1 Introduction
14.2 Literature Review
14.3 Predictive Analytics
14.3.1 How Predictive Analytics Works
14.3.2 Techniques Used in Predictive Analytics
14.4 Healthcare
14.5 Roles of Predictive Analytics in Healthcare
14.6 Technologies Supporting Predictive Analytics in Healthcare
14.7 Challenges in Implementing Predictive Analytics in Healthcare
14.8 Conclusion
References
15. Effect of Packaging Material in the Supply Chain: A Case Study of Dairy PackagingSaureng Kumar and Ankita Panwar
15.1 Introduction
15.2 Literature Review
15.3 Material and Method
15.4 Result
15.5 Conclusion
References
16. The Role of Machine Learning in Advancing Intelligent
Conversational SystemsSonu Rana, Ayantika Das, Shankar Prasad Mitra and Riya Sil
16.1 Introduction
16.2 Literature Review
16.3 Role of Machine Learning in Conversational AI Development
16.3.1 Data Collection and Preprocessing
16.3.2 Natural Language Understanding (NLU)
16.3.3 Dialogue Management (DM)
16.3.4 Natural Language Generation (NLG)
16.4 Training and Evaluation
16.4.1 Supervised and Unsupervised Learning
16.4.2 Fine-Tuning Pre-Trained Models
16.4.3 Evaluation of Machine Learning (ML)
16.4.4 Feedback and Refinement
16.4.5 Deployment and Maintenance
16.5 Advanced Topics and Emerging Trends
16.5.1 Multimodal AI
16.5.2 Zero-Shot and Few-Shot Learning
16.6 Ethical Considerations
16.7 Conclusion
References
17. A Data-Driven Approach to Predicting Dengue Fever: Integrating Climate Data and Machine LearningEswar Reddy and Tannistha Pal
17.1 Introduction
17.2 Literature Review
17.3 Dataset and Features
17.4 Proposed Method
17.5 Results
17.6 Discussion
17.7 Conclusion
References
Index Back to Top